Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP733309.RA_PP1Y4DMMldzBWIjjEKqWUt0I1Gtvk_kipr3BT65G_0130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP733309.RA_PP1Y4DMMldzBWIjjEKqWUt0I1Gtvk_kipr3BT65G_0130_assertion type Assertion NP733309.RA_PP1Y4DMMldzBWIjjEKqWUt0I1Gtvk_kipr3BT65G_0130_head.
- NP733309.RA_PP1Y4DMMldzBWIjjEKqWUt0I1Gtvk_kipr3BT65G_0130_assertion description "[This study suggests that despite the infrequent incidence of the IDH1 mutations in prostate cancers and B-ALL, mutated IDH1 could be therapeutically targeted in these cancers and in glial tumors with the IDH1 mutations.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP733309.RA_PP1Y4DMMldzBWIjjEKqWUt0I1Gtvk_kipr3BT65G_0130_provenance.
- NP733309.RA_PP1Y4DMMldzBWIjjEKqWUt0I1Gtvk_kipr3BT65G_0130_assertion evidence source_evidence_literature NP733309.RA_PP1Y4DMMldzBWIjjEKqWUt0I1Gtvk_kipr3BT65G_0130_provenance.
- NP733309.RA_PP1Y4DMMldzBWIjjEKqWUt0I1Gtvk_kipr3BT65G_0130_assertion SIO_000772 19378339 NP733309.RA_PP1Y4DMMldzBWIjjEKqWUt0I1Gtvk_kipr3BT65G_0130_provenance.
- NP733309.RA_PP1Y4DMMldzBWIjjEKqWUt0I1Gtvk_kipr3BT65G_0130_assertion wasDerivedFrom befree-2016 NP733309.RA_PP1Y4DMMldzBWIjjEKqWUt0I1Gtvk_kipr3BT65G_0130_provenance.
- NP733309.RA_PP1Y4DMMldzBWIjjEKqWUt0I1Gtvk_kipr3BT65G_0130_assertion wasGeneratedBy ECO_0000203 NP733309.RA_PP1Y4DMMldzBWIjjEKqWUt0I1Gtvk_kipr3BT65G_0130_provenance.